Butenafine

Drug Profile

Butenafine

Alternative Names: Butena; Butenafide; Butenafide hydrochloride; Butenafine hydrochloride; Dermacom; Dermax; Dr. Scholl's; Fintop; Funcid; Ingebut; KP 363; Lotrimin Ultra; Mentax; Volley; Zaxem

Latest Information Update: 25 Mar 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Kaken Pharmaceutical
  • Developer Kaken Pharmaceutical; Merck & Co
  • Class Antifungals; Naphthalenes; Small molecules
  • Mechanism of Action Squalene monooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Mycoses; Onychomycosis; Pityriasis versicolor; Tinea corporis; Tinea cruris; Tinea pedis

Most Recent Events

  • 10 Jul 2007 No development reported - Phase-III for Onychomycosis in USA (PO)
  • 07 Sep 2004 Added Sinphar and Hanlim to Company table
  • 10 Jul 2004 Launched for Mycoses in China (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top